179 related articles for article (PubMed ID: 27622361)
1. Inflammation, Genetics, Dysbiosis, and the Environment: New Paradigms for Diagnosis in Complex Chronic Gut Syndromes.
Walker MM
J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S4-5. PubMed ID: 27622361
[TBL] [Abstract][Full Text] [Related]
2. Development of an Index Score for Intestinal Inflammation-Associated Dysbiosis Using Real-World Stool Test Results.
Chen L; Reynolds C; David R; Peace Brewer A
Dig Dis Sci; 2020 Apr; 65(4):1111-1124. PubMed ID: 31529411
[TBL] [Abstract][Full Text] [Related]
3. Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals.
Heinzel S; Jureczek J; Kainulainen V; Nieminen AI; Suenkel U; von Thaler AK; Kaleta C; Eschweiler GW; Brockmann K; Aho VTE; Auvinen P; Maetzler W; Berg D; Scheperjans F
Sci Rep; 2024 Jun; 14(1):13513. PubMed ID: 38866914
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of the human gut microbiome in inflammatory bowel disease.
Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
[TBL] [Abstract][Full Text] [Related]
5. Infant Colic Represents Gut Inflammation and Dysbiosis.
Rhoads JM; Collins J; Fatheree NY; Hashmi SS; Taylor CM; Luo M; Hoang TK; Gleason WA; Van Arsdall MR; Navarro F; Liu Y
J Pediatr; 2018 Dec; 203():55-61.e3. PubMed ID: 30177353
[TBL] [Abstract][Full Text] [Related]
6. [Faecal calprotectin is a useful biomarker for intestinal inflammation].
Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Nielsen AM
Ugeskr Laeger; 2014 Sep; 176(37):. PubMed ID: 25294035
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiota and inflammatory bowel diseases.
Miyoshi J; Chang EB
Transl Res; 2017 Jan; 179():38-48. PubMed ID: 27371886
[TBL] [Abstract][Full Text] [Related]
8. Fecal calprotectin in inflammatory bowel diseases: update and perspectives.
Manceau H; Chicha-Cattoir V; Puy H; Peoc'h K
Clin Chem Lab Med; 2017 Mar; 55(4):474-483. PubMed ID: 27658156
[TBL] [Abstract][Full Text] [Related]
9. [Fecal Calprotectin in Inflammatory Bowel Disease].
Lee J
Korean J Gastroenterol; 2016 May; 67(5):233-7. PubMed ID: 27206433
[TBL] [Abstract][Full Text] [Related]
10. Immunoanalytical characteristics of fecal calprotectin.
Desbène C; Gaillard O; Kapel N
Ann Biol Clin (Paris); 2016 Dec; 74(6):725-734. PubMed ID: 27848924
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease.
Iborra M; Beltrán B; Nos P
Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):641-56. PubMed ID: 27633593
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
Putignani L; Del Chierico F; Vernocchi P; Cicala M; Cucchiara S; Dallapiccola B;
Inflamm Bowel Dis; 2016 Feb; 22(2):487-504. PubMed ID: 26588090
[TBL] [Abstract][Full Text] [Related]
13. Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives.
Chaabouni T; Manceau H; Peoc'h K
Ann Biol Clin (Paris); 2016 Aug; 74(4):385-94. PubMed ID: 27492691
[TBL] [Abstract][Full Text] [Related]
14. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
[TBL] [Abstract][Full Text] [Related]
15. Fecal biomarkers in inflammatory bowel disease.
Lopez RN; Leach ST; Lemberg DA; Duvoisin G; Gearry RB; Day AS
J Gastroenterol Hepatol; 2017 Mar; 32(3):577-582. PubMed ID: 27723123
[TBL] [Abstract][Full Text] [Related]
16. [Fecal calprotectin in the diagnosis of inflammatory bowel diseases].
Rodríguez-Moranta F; Lobatón T; Rodríguez-Alonso L; Guardiola J
Gastroenterol Hepatol; 2013; 36(6):400-6. PubMed ID: 23434080
[TBL] [Abstract][Full Text] [Related]
17. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
[TBL] [Abstract][Full Text] [Related]
18. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention.
Aleksandrova K; Romero-Mosquera B; Hernandez V
Nutrients; 2017 Aug; 9(9):. PubMed ID: 28867793
[TBL] [Abstract][Full Text] [Related]
19. [Fecal lactoferrin in identifying and management of inflammatory bowel disease].
Pac-Kozuchowska E; Krawiec P; Mroczkowska-Juchkiewicz A
Pol Merkur Lekarski; 2014 Jul; 37(217):61-4. PubMed ID: 25154203
[TBL] [Abstract][Full Text] [Related]
20. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.
Lozoya Angulo ME; de Las Heras Gómez I; Martinez Villanueva M; Noguera Velasco JA; Avilés Plaza F
Gastroenterol Hepatol; 2017 Mar; 40(3):125-131. PubMed ID: 27260632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
